vs

Side-by-side financial comparison of MNTN, Inc. (MNTN) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

MNTN, Inc. is the larger business by last-quarter revenue ($2.0B vs $83.1M, roughly 24.3× PROCEPT BioRobotics Corp). MNTN, Inc. runs the higher net margin — 1.7% vs -38.1%, a 39.8% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -0.0%).

MNTN Inc. is a U.S.-headquartered advertising technology firm specializing in performance-driven connected TV (CTV) advertising solutions. It serves e-commerce, retail, and consumer goods brands, helping clients accurately measure ad campaign ROI and reach targeted audiences across streaming TV platforms in North American and European markets.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

MNTN vs PRCT — Head-to-Head

Bigger by revenue
MNTN
MNTN
24.3× larger
MNTN
$2.0B
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+20.2% gap
PRCT
20.2%
-0.0%
MNTN
Higher net margin
MNTN
MNTN
39.8% more per $
MNTN
1.7%
-38.1%
PRCT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
MNTN
MNTN
PRCT
PRCT
Revenue
$2.0B
$83.1M
Net Profit
$34.5M
$-31.6M
Gross Margin
100.0%
64.9%
Operating Margin
97.5%
-4.1%
Net Margin
1.7%
-38.1%
Revenue YoY
-0.0%
20.2%
Net Profit YoY
-27.9%
EPS (diluted)
$0.43
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MNTN
MNTN
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$2.0B
$76.4M
Q3 25
$70.0M
$83.3M
Q2 25
$68.5M
$79.2M
Q1 25
$69.2M
Q4 24
$68.2M
Q3 24
$58.4M
Q2 24
$53.4M
Net Profit
MNTN
MNTN
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$34.5M
$-29.8M
Q3 25
$6.4M
$-21.4M
Q2 25
$-26.2M
$-19.6M
Q1 25
$-24.7M
Q4 24
$-18.9M
Q3 24
$-21.0M
Q2 24
$-25.6M
Gross Margin
MNTN
MNTN
PRCT
PRCT
Q1 26
64.9%
Q4 25
100.0%
60.6%
Q3 25
78.9%
64.8%
Q2 25
76.8%
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
MNTN
MNTN
PRCT
PRCT
Q1 26
-4.1%
Q4 25
97.5%
-40.6%
Q3 25
10.8%
-27.8%
Q2 25
5.4%
-28.0%
Q1 25
-39.7%
Q4 24
-28.9%
Q3 24
-38.4%
Q2 24
-50.3%
Net Margin
MNTN
MNTN
PRCT
PRCT
Q1 26
-38.1%
Q4 25
1.7%
-39.1%
Q3 25
9.2%
-25.7%
Q2 25
-38.3%
-24.7%
Q1 25
-35.8%
Q4 24
-27.6%
Q3 24
-35.9%
Q2 24
-48.0%
EPS (diluted)
MNTN
MNTN
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.43
$-0.54
Q3 25
$0.08
$-0.38
Q2 25
$-0.65
$-0.35
Q1 25
$-0.45
Q4 24
$-0.34
Q3 24
$-0.40
Q2 24
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MNTN
MNTN
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$210.2M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$347.7M
Total Assets
$378.3M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MNTN
MNTN
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$210.2M
$286.5M
Q3 25
$179.2M
$294.3M
Q2 25
$175.2M
$302.7M
Q1 25
$316.2M
Q4 24
$333.7M
Q3 24
$196.8M
Q2 24
$214.1M
Total Debt
MNTN
MNTN
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
MNTN
MNTN
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$365.9M
Q3 25
$266.7M
$380.3M
Q2 25
$238.9M
$385.8M
Q1 25
$389.2M
Q4 24
$402.2M
Q3 24
$241.2M
Q2 24
$251.8M
Total Assets
MNTN
MNTN
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$378.3M
$508.1M
Q3 25
$335.9M
$511.5M
Q2 25
$337.0M
$513.1M
Q1 25
$519.4M
Q4 24
$534.0M
Q3 24
$374.1M
Q2 24
$374.4M
Debt / Equity
MNTN
MNTN
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MNTN
MNTN
PRCT
PRCT
Operating Cash FlowLast quarter
$56.5M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.64×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MNTN
MNTN
PRCT
PRCT
Q1 26
Q4 25
$56.5M
$-10.3M
Q3 25
$9.3M
$-6.6M
Q2 25
$17.6M
$-15.0M
Q1 25
$-17.0M
Q4 24
$-32.4M
Q3 24
$-18.8M
Q2 24
$-15.7M
Free Cash Flow
MNTN
MNTN
PRCT
PRCT
Q1 26
Q4 25
$-12.2M
Q3 25
$-9.5M
Q2 25
$-17.8M
Q1 25
$-18.8M
Q4 24
$-33.6M
Q3 24
$-19.0M
Q2 24
$-16.8M
FCF Margin
MNTN
MNTN
PRCT
PRCT
Q1 26
Q4 25
-15.9%
Q3 25
-11.4%
Q2 25
-22.5%
Q1 25
-27.2%
Q4 24
-49.2%
Q3 24
-32.6%
Q2 24
-31.4%
Capex Intensity
MNTN
MNTN
PRCT
PRCT
Q1 26
Q4 25
2.4%
Q3 25
3.4%
Q2 25
3.5%
Q1 25
2.7%
Q4 24
1.7%
Q3 24
0.4%
Q2 24
2.0%
Cash Conversion
MNTN
MNTN
PRCT
PRCT
Q1 26
Q4 25
1.64×
Q3 25
1.45×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MNTN
MNTN

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons